Frontier Biology (688221.SH) released its 2024 semi-annual report, with the company achieving revenue of 5 million yuan during the reporting period...
According to the 2024 semi-annual report released by Frontier Biology (688221.SH), the company achieved revenue of 51.056 million yuan during the reporting period, a year-on-year growth of 20.30%. The net loss attributable to shareholders of the listed company was 0.16 billion yuan; the net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 0.176 billion yuan; the basic loss per share was 0.43 yuan/share.
